Sonova (OTCMKTS:SONVY) Sets New 1-Year High – Should You Buy?

Sonova Holding (OTCMKTS:SONVY)’s share price hit a new 52-week high during mid-day trading on Monday. The stock traded as high as $69.01 and last traded at $69.01, with a volume of 4,451 shares traded. The stock had previously closed at $68.52.

Analyst Ratings Changes

Several research analysts have commented on SONVY shares. The Goldman Sachs Group raised Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. Citigroup restated a “sell” rating on shares of Sonova in a research note on Friday, July 24th. Finally, UBS Group upgraded Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Sonova presently has an average rating of “Moderate Buy”.

Sonova Stock Performance

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The firm’s 50-day simple moving average is $60.29 and its 200 day simple moving average is $53.70.

About Sonova

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.